Filed 7mo ago· Oct 28, 2025
4 days to disclose
Marjorie Taylor Greene
RHouseGeorgia-14
↑bought
Amgen
AMGN
$1K-$15K
+11.1% vs S&P 500
Trade dateOct 24, 2025
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.

































| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Oct 28, 2025 7mo ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Amgen AMGN | Oct 24, 2025 4 days to disclose | Good buy·+$1K+12.8% +11.1% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 20, 2025 7mo ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Novo Nordisk NVO | Oct 15, 2025 5 days to disclose | Bad buy·−$1.5K-19.3% −23.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 27, 2025 8mo ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Amgen AMGN | Sep 11, 2025 16 days to disclose | Good buy·+$1.3K+16.4% +10.1% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 29, 2025 9mo ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Merck MRK Stock | Aug 28, 2025 1 day to disclose | Good buy·+$2.9K+36.5% +27.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 29, 2025 9mo ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Novo Nordisk NVO | Aug 28, 2025 1 day to disclose | Bad buy·−$1.5K-18.4% −27.3% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Novo Nordisk NVO | Aug 19, 2025 1 day to disclose | Bad buy·−$5.4K-16.5% −25.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 15, 2025 9mo ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | AbbVie ABBV | Aug 4, 2025 11 days to disclose | Good buy·+$749+9.4% −2.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 18, 2025 11mo ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Gilead Sciences GILD | Jun 6, 2025 12 days to disclose | Good buy·+$1.6K+20.1% +9.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2025 1.0y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Eli Lilly LLY | May 14, 2025 5 days to disclose | Good buy·+$4K+49.5% +34.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 19, 2025 1.0y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Amgen AMGN | May 14, 2025 5 days to disclose | Good buy·+$2K+25.4% +10.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Gilead Sciences GILD | May 5, 2025 1 day to disclose | Good buy·+$2.5K+31.4% +23.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | May 5, 2025 1 day to disclose | Good buy·+$3.9K+49.2% +41.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Gilead Sciences GILD | May 5, 2025 1 day to disclose | Good buy·+$2.5K+31.4% +23.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Merck MRK Stock | May 5, 2025 1 day to disclose | Good buy·+$3K+37.1% +29.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Eli Lilly LLY | May 5, 2025 1 day to disclose | Good buy·+$2.4K+30.2% +22.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | AbbVie ABBV | May 5, 2025 1 day to disclose | Good buy·+$799+10.0% +2.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Amgen AMGN | May 5, 2025 1 day to disclose | Good buy·+$1.4K+17.5% +10.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Merck MRK Stock | Apr 9, 2025 2 days to disclose | Good buy·+$3.1K+38.6% +31.6% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 19, 2025 1.2y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | AbbVie ABBV | Mar 17, 2025 2 days to disclose | Good buy·+$44+0.6% −0.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 27, 2025 1.3y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Eli Lilly LLY | Jan 21, 2025 6 days to disclose | Good buy·+$3.5K+44.1% +39.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 27, 2025 1.3y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | Jan 8, 2025 19 days to disclose | Good buy·+$5K+62.6% +56.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 27, 2025 1.3y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | Jan 8, 2025 19 days to disclose | Good buy·+$5K+62.6% +56.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 27, 2025 1.3y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | Jan 8, 2025 19 days to disclose | Good buy·+$5K+62.6% +56.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 27, 2024 1.4y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Gilead Sciences GILD | Dec 24, 2024 3 days to disclose | Good buy·+$3.5K+43.8% +37.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 27, 2024 1.4y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Eli Lilly LLY | Dec 24, 2024 3 days to disclose | Good buy·+$2.8K+34.4% +27.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 27, 2024 1.4y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | Dec 24, 2024 3 days to disclose | Good buy·+$4.7K+58.6% +52.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 27, 2024 1.5y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | Nov 25, 2024 2 days to disclose | Good buy·+$3.9K+48.5% +46.3% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 27, 2024 1.5y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | GSK PLC GSK | Nov 25, 2024 2 days to disclose | Good buy·+$3.8K+48.0% +45.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2024 1.5y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | AbbVie ABBV | Nov 20, 2024 1 day to disclose | Good buy·+$2.3K+28.5% +24.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 4, 2024 1.7y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | GSK PLC GSK | Sep 3, 2024 1 day to disclose | Good buy·+$2K+25.3% −4.0% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 7, 2022 4.2y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Amgen AMGN | Feb 22, 2022 13 days to disclose | Good buy·+$4.4K+55.6% −10.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 4, 2021 4.8y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Amgen AMGN | Jul 19, 2021 16 days to disclose | Good buy·+$3.2K+39.6% −28.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 21, 2021 5.0y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | AbbVie ABBV | Jun 16, 2021 5 days to disclose | Good buy·+$5.8K+72.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |